期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

细胞外基质金属蛋白酶诱导因子在动脉粥样硬化发展进程中的相关研究进展 被引量：3

在线阅读 下载PDF
导出
摘要 细胞外基质金属蛋白酶诱导因子在多种细胞表达并诱导基质金属蛋白酶产生,近期有较多研究表明,细胞外基质金属蛋白酶诱导因子在动脉粥样硬化相关细胞以及人类动脉粥样斑块内高表达,推测其在动脉粥样硬化的病理生理中可能起到重要的作用。
作者 袁伟 何奔 葛恒
机构地区 上海交通大学医学院附属仁济医院心内科
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第7期582-584,共3页 Chinese Journal of Arteriosclerosis
关键词 病理学与病理生理学 细胞外基质金属蛋白酶诱导因子 基质金属蛋白酶 动脉粥样硬化
分类号 R363 [医药卫生—病理学]
  • 相关文献

参考文献22

  • 1Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracelluar matrix metalloproteinase inducer interactions [J]. Cancer Res, 2001, 61 (5) : 2 276-281.
  • 2Caudroy S, Polette M, Nawrocki-Raby B, et al. EMMPRIN-mediated MMP regulation in tumor and endothelial cells [J]. Clin Exp Met, 2002, 19(8): 697-702.
  • 3Major TC, Liang L, Lu X, et al. Extracellular matrix metalloproteinase induced(EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma[J].Arterioscler Thromb Vasc Biol, 2002, 22 (7) : 1 200-207.
  • 4Yoon YW, Kwon HM, Hwang KC, et al. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque [J]. Atherosclerosis , 2005, 180 (1): 37-44.
  • 5Sluijter JP,Pulskens WP,Schoneveld AH,et al.Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinase 8 and 9 with vulnerable carotid atherosclerotic lesions:a study in human endarterectomy specimen pointing to a role for different extracelluar matrix metalloproteinase inducer glycosylation forms[J].Strock,2006,37(1):235-239.
  • 6Liang L, Major T, Bocan T. Characterization of the promoter of human extracellular matrix metalloproteinase inducer ( EMMPRIN) [ J ].Gene, 2002, 282 ( 1-2 ) : 75-86.
  • 7Tang Y, Kesavan P, Nakada MT, et al. Tumor-stroma interaction: Positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN [J]. Mol Cancer Res, 2004, 2 (2) : 73-80.
  • 8Sidhu SS, Mengistab AT, Tauscher AN, et al. The microvesicle as a vehicle for EMMPRIN in tumor stromal interactions [J]. Oncogene,2004, 23 (4): 956-963.
  • 9王长谦,汤大鸣,谢秀兰,徐依敏,丁弘毅,王利民,王彬尧,黄定九.氧化型低密度脂蛋白对人血单核细胞基质金属蛋白酶表达及活性的影响[J].中国动脉硬化杂志,2003,11(2):126-130. 被引量：13
  • 10Nabeshima K, Iwasaki H. Koga K, et al. Emmprin (basigin/CD147) : Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays acritical role in carncer progression [J]. Pathol Int, 2006, 56 (7): 359-367.

二级参考文献38

  • 1邓平,赵水平.环氧合酶2在动脉粥样硬化炎症中的意义和他汀类药物的影响[J].中国动脉硬化杂志,2004,12(2):241-242. 被引量：6
  • 2沈彬,吴宗贵.C反应蛋白对U937细胞表达基质金属蛋白酶2的影响[J].中国动脉硬化杂志,2005,13(1):25-28. 被引量：5
  • 3陈样新,傅国胜,徐耕,单江.急性冠状动脉综合征患者血清基质金属蛋白酶2的变化[J].中国动脉硬化杂志,2005,13(3):363-366. 被引量：7
  • 4金冬雁 黎孟枫（译）.分子克隆（第二版）[M].北京:科学出版社,1995..
  • 5Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med, 1999, 340 (2): 115-126.
  • 6Vlaicu R, Rus HG, Niculescu F, Cristea A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis, 1985, 55 (1): 35-50.
  • 7Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 1998, 18 (9): 1 386-392.
  • 8Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis, 1999, 145 (2): 375-379.
  • 9Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation, 2002, 105 (17): 2 019-023.
  • 10Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 2000, 102 (18): 2 165-168.

共引文献30

同被引文献56

  • 1Jianglin Fan,Teruo Watanabe,王燕翻.炎症反应在动脉粥样硬化发病学中的作用[J].中国动脉硬化杂志,2003,11(7):706-708. 被引量：15
  • 2范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量：73
  • 3杜景民,卞金陵,章建梁.牛磺酸对动脉粥样硬化大鼠NO,AngⅡ含量和ACE活性的影响[J].中国老年学杂志,2006,26(2):235-237. 被引量：6
  • 4Perbal B. CCN proteins: multifunctional signaling regulators[ J ]. Lancet, 2004, 363 (9 402) : 62-64.
  • 5Shu-Wen X, Lessk A, Abraham D. Regulation and function of connectivetissue growth factor/CCN2 in tissue repair, scarring and fibrosis [ J ]. Cytokine Growth Factor Rev, 2008, 19 (2) : 133-144.
  • 6Hussain A, Wyatt AW, Wang K, et al. SGKl-dependent upregulation of connective tissue growth factor by angiotensin II [ J]. Kidney Blood Press Res, 2008, 31 (2) : 80-86.
  • 7Recchia AG, Filice E, Pelleqrlno D, et al, Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes [ J ]. J Mol Cell Cardiol, 2009, 46 (3): 352-359.
  • 8Eguchi T, Kubota S, Kawata K, et al. Novel transcription factor-like function of human matrix metalloproteinaze 3 regulating the CTGF/CCN2 gene [J]. Mol Cell Biol, 2008, 28 (7) : 2 391413.
  • 9Liu X, Luo F. Pan K, et al. High gluease up regulates connective dssue growth factor expression in human vascular smooth muscle cells[ J ]. BMC Cell Biol, 2007, 8: 1-12.
  • 10Koitabashi N, Arai M, Kogure S, et al. Increased connective tissue growth factor relative to brain natriurefic pepfide as a determinant of myocardial fibrosis [J]. Hypertension, 2007, 49 (5) :1 120-127.

引证文献3

二级引证文献13

中国动脉硬化杂志
2008年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部